These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36869600)

  • 1. Non-alcoholic steatohepatitis is independently associated with a history of gestational diabetes mellitus.
    Boustany A; Onwuzo S; Zeid HKA; Almomani A; Kumar P; Hitawala A; Asaad I
    J Gastroenterol Hepatol; 2023 Jun; 38(6):984-988. PubMed ID: 36869600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of non-alcoholic fatty liver disease and factors associated with it in Indian women with a history of gestational diabetes mellitus.
    Kubihal S; Gupta Y; Shalimar ; Kandasamy D; Goyal A; Kalaivani M; Goyal A; Kedia S; Kachhawa G; Ambekar S; Bhatia D; Garg V; Gupta N; Tandon N
    J Diabetes Investig; 2021 May; 12(5):877-885. PubMed ID: 32961610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevalence and clinical features of non-alcoholic steatohepatitis in a hypertensive population].
    García-Carretero R; Barquero-Pérez O; Mora-Jiménez I; Soguero-Ruiz C; Goya-Esteban R; Rodríguez-Castro C; Ramos-López J
    Hipertens Riesgo Vasc; 2019; 36(3):130-136. PubMed ID: 30655210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated plasma copeptin levels identify the presence and severity of non-alcoholic fatty liver disease in obesity.
    Barchetta I; Enhörning S; Cimini FA; Capoccia D; Chiappetta C; Di Cristofano C; Silecchia G; Leonetti F; Melander O; Cavallo MG
    BMC Med; 2019 Apr; 17(1):85. PubMed ID: 31035998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of de novo post-transplant type 2 diabetes in patients undergoing liver transplant for non-alcoholic steatohepatitis.
    Stepanova M; Henry L; Garg R; Kalwaney S; Saab S; Younossi Z
    BMC Gastroenterol; 2015 Dec; 15():175. PubMed ID: 26666336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epidemiology of non-alcoholic steatohepatitis (NASH) in the United States between 2010-2020: a population-based study.
    Hamid O; Eltelbany A; Mohammed A; Alsabbagh Alchirazi K; Trakroo S; Asaad I
    Ann Hepatol; 2022; 27(5):100727. PubMed ID: 35700934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risk of non-alcoholic fatty liver disease in women with gestational diabetes mellitus: A population-based cohort study, systematic review and meta-analysis.
    Lavrentaki A; Thomas T; Subramanian A; Valsamakis G; Thomas N; Toulis KA; Wang J; Daly B; Saravanan P; Sumilo D; Mastorakos G; Tahrani AA; Nirantharakumar K
    J Diabetes Complications; 2019 Oct; 33(10):107401. PubMed ID: 31326267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Characteristics and Metabolic Profiles of Non-Alcoholic Fatty Liver Disease (NAFLD) in Lean Patients and Their Comparison with Obese and Overweight NAFLD.
    Chakrabarty M; Jha AN; Sharma DJ
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and Specific Manifestations of Non-alcoholic Fatty Liver Disease (NAFLD) and Diabetes Mellitus Type 2 Association in a Moroccan Population: A Cross-sectional Study.
    Assarrar I; Messaoudi N; Ongoth FEM; Abdellaoui W; Malki A; Rouf S; Abda N; Ismaili Z; Latrech H
    Rev Diabet Stud; 2022 Sep; 18(3):140-145. PubMed ID: 36309775
    [No Abstract]   [Full Text] [Related]  

  • 10. Ectodysplasin A Is Increased in Non-Alcoholic Fatty Liver Disease, But Is Not Associated With Type 2 Diabetes.
    Bayliss J; Ooi GJ; De Nardo W; Shah YJH; Montgomery MK; McLean C; Kemp W; Roberts SK; Brown WA; Burton PR; Watt MJ
    Front Endocrinol (Lausanne); 2021; 12():642432. PubMed ID: 33746906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of gestational diabetes (GDM) and long-term risk of diabetes and metabolic syndrome: findings from the RADIEL study follow-up.
    Huvinen E; Eriksson JG; Koivusalo SB; Grotenfelt N; Tiitinen A; Stach-Lempinen B; Rönö K
    Acta Diabetol; 2018 May; 55(5):493-501. PubMed ID: 29460080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Non-alcoholic fatty liver disease and type 2 diabetes mellitus. I. Pathogenesis].
    Pár A; Wittmann I; Pár G
    Orv Hetil; 2022 May; 163(21):815-825. PubMed ID: 35598211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Alcoholic Fatty Liver Disease Treatment in Patients with Type 2 Diabetes Mellitus; New Kids on the Block.
    Athyros VG; Polyzos SA; Kountouras J; Katsiki N; Anagnostis P; Doumas M; Mantzoros CS
    Curr Vasc Pharmacol; 2020; 18(2):172-181. PubMed ID: 30961499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon-Like Peptide-1 Receptor Agonists and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity/Metabolic Syndrome, Prediabetes/Diabetes and Non-Alcoholic Fatty Liver Disease-Current Evidence.
    Muzurović EM; Volčanšek Š; Tomšić KZ; Janež A; Mikhailidis DP; Rizzo M; Mantzoros CS
    J Cardiovasc Pharmacol Ther; 2022; 27():10742484221146371. PubMed ID: 36546652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of gestational diabetes mellitus in women diagnosed with non-alcoholic fatty liver disease during pregnancy: A systematic review and meta-analysis.
    Chai TYL; Rajaratnam RM; Deng D; George J; Pasupathy D; Cheung NW
    J Diabetes Complications; 2021 Sep; 35(9):107991. PubMed ID: 34219018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Correlates of Non-alcoholic Steatohepatitis in Nigerian Patients with Metabolic Syndrome.
    Obasi E; Adekanle E; Ajayi NA; Ndububa DA
    West Afr J Med; 2022 Apr; 39(4):407-414. PubMed ID: 35490415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-alcoholic fatty liver disease in the first trimester and subsequent development of gestational diabetes mellitus.
    Lee SM; Kwak SH; Koo JN; Oh IH; Kwon JE; Kim BJ; Kim SM; Kim SY; Kim GM; Joo SK; Koo BK; Shin S; Vixay C; Norwitz ER; Park CW; Jun JK; Kim W; Park JS
    Diabetologia; 2019 Feb; 62(2):238-248. PubMed ID: 30470912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathological differences in patients with biopsy-proven non-alcoholic fatty liver disease with and without type 2 diabetes.
    Aller de la Fuente R; Mora Cuadrado N; Tafur C; López Gómez JJ; Gómez de la Cuesta S; García Sánchez MC; Antolin Melero B; de Luis Román DA
    Endocrinol Diabetes Nutr (Engl Ed); 2018; 65(6):354-360. PubMed ID: 29477355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Concurrent Type 2 Diabetes Mellitus and Non-Alcoholic Steatohepatitis: A Review of the Evidence.
    Yabiku K
    Front Endocrinol (Lausanne); 2021; 12():768850. PubMed ID: 34950104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus.
    Boney CM; Verma A; Tucker R; Vohr BR
    Pediatrics; 2005 Mar; 115(3):e290-6. PubMed ID: 15741354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.